Computerized logP prediction using fragment methods;Szamitogepes logP predikcio fragmens modszerek alkalmazasaval

Acta Pharmaceutica Hungarica

Volumn 68, Issue 1, 1998, Pages 39-48

  Takácsné Novák, Krisztina ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

A 2545; AMINOPHENAZONE; ARECOLINE; ASCORBIC ACID; ATENOLOL; BUSPIRONE; CDD 0040; CDD 0098; CHLORPROMAZINE; CODEINE; EPHEDRINE; FLUMEQUINE; KHL 8430; MEXILETINE; MORPHINE; NIFLUMIC ACID; OFLOXACIN; PAPAVERINE; PARACETAMOL; PHENOBARBITAL; PILOCARPINE; PROCAINE; PYRIDOXINE; SALICYLIC ACID; SELEGILINE; UNCLASSIFIED DRUG; VE 1582; DRUG; OCTANOL; WATER;

ANALYTIC METHOD; CALCULATION; PHARMACEUTICS; PREDICTION; REVIEW; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER PROGRAM; COMPUTER SIMULATION; CONFORMATION; PREDICTION AND FORECASTING; SOLUBILITY; STRUCTURE ACTIVITY RELATION;

COMPUTER SIMULATION; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; OCTANOLS; PHARMACEUTICAL PREPARATIONS; PREDICTIVE VALUE OF TESTS; SOFTWARE; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; WATER;

EID: 0031602748     PISSN: 00016659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Kubinyi, H.: Pharmazie 50, 647 (1995).
2. Testa, B., Carrupt, P.-A., Gaillard, P., Tsai, R.-S.: Intramolecular Interactions Encoded in Lipophilicity: Their Nature and Significance. In: Pliska, V., Testa, B., Van de Waterbeemd, H. (Eds): Lipophilicity in Drug Action and Toxicology. VCH, Weinheim, 1996. p. 49.
3. Leo, A., Hansch, C., Elkins, D.: Chem. Rev. 71, 525 (1971).
4. Takácsné Novák K.: Acta Pharm. Hung. 67, 179 (1997).
5. Leo, A.: Chem Rev. 93, 1281 (1993).
6. Leo, A.: The Future of logP Calculation. In Pliska, V., Testa, B., Van de Waterbeemd, H. (Eds): Lipophilicity in Drug Action and Toxicology. VCH, Weinheim, 1996. p. 157.
7. Van de Waterbeemd, H.: Hydrophobicity of Organic Compounds: How to Calculate it by Personal Computer, Booksoft series, Vol. 1. (Ed.): Darvas F. Compudrug International Vienna, 1986
8. Van de Waterbeemd, H., Mannhold, R.: Lipophilicity Descriptors for Structure-Property Correlation Studies: Overview of Experimental and Theoretical Methods and a Benchmark of logP Calculations. In Pliska, V., Testa, B., Van de Wa-terbeemd, H. (Eds): Lipophilicity in Drug Action and Toxicology. VCH, Weinheim, 1996, p. 401.
9. Rekker, R. F.: The Hydrophobic Fragmental Constant, in Pharmacochemistry Library Vol. 1. (Ed.): Timmerman, H. Elsevier, Amsterdam, 1977.
10. Rekker, R. F., Mannhold, R.: Calculation of Drug Lipophilicity. VCH, Weinheim, 1992.
11. Leo, A., Jow, P. Y. C., Silipo, C., Hansch, C.: J. Med. Chem. 18, 865 (1975).
12. Mansch, C., Leo, A.: Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley, New York, 1979.
13. Fujita, T., Iwasa, J., Hansch, C.: J. Amer. Chem. Soc. 86, 5175 (1964).
14. Broto, P., Moreau, G., Vandyke, C.: Eur. J. Med. Chem. 19, 71 (1984).
15. Ghose, A. K., Crippen, G. M.: J. Med. Chem. 28, 333 (1985).
16. Klopman, G., Li, J.-Y., Wang, S., Dimayuga, M.: J. Chem. Inf. Comput. Sci. 34, 752, (1994).
17. Suzuki, T., Kudo, Y.: J. Comput.-Aid. Mol. Des. 4, 155 (1990).
18. PROLOGP Version 5.1. Compudrug, Budapest, 1995.
19. Petelin, D. E., Arslanov, N. A., Paulyulin, V. A., Zefiror, N. S.: 10th. Eur. Symp. on Structure-Activity Relationships, (1994.) Abstract B263.
20. CLOGP, logP Calculation Algorithm. Pomona College, Medicinal Chemistry Project, Claremont, CA, 91711, USA.
21. Meylan, W., Howard, P.: J. Pharm. Sci. 84, 83 (1995).
22. Masuda, T., Jikihara, J., Nakamura, K., Kimura, A., Takagi, T., Fujiwara, H.: J. Pharm. Sci. 86, 57 (1997).
23. Kellogg, G. E., Abraham, M. H.: J. Comput.-Aid. Mol. Des. 5, 545 (1991).
24. Aurdy, E., Dallet, p., Langlois, M. H., Colleter, J. C., Dubost, J. P.: Prog. Clin. Biol. Res. 292, 63 (1989).
25. Abraham, D. J., Kellogg, G. E.: Hydrophobic Fields. In: 3D QSAR in Drug Design. Kubinyi, H. (Ed.). Escom, Leiden, 1993. p.506.
26. Convard, T., Dubost, J. P., Le Sollen, H., Kummer, E.: Quant. Struct.-Act. Relat. 13, 34 (1994).
27. Rogers, K., Cammarata, A.: Biochim. Biophys. Acta 193, 22 (1969).
28. Klopman, G., Iroff, L. D.: J. Comput. Chem. 2, 157 (1981).
29. Bodor, N., Huang, M. J.: J. Pharm. Sci. 81, 272 (1992).
30. Hopfinger, A., Battershell, R.: J. Med. Chem. 19, 569 (1976).
31. Dunn, W. III., Koehler, M. G., Grigoras, S.: J. Med. Chem. 30, 1121 (1987).
32. Richards, W. G.: Theoretical Calculation of Partition Coefficients. In: Pliska, V., Testa, B., Van de Waterbeemd, H. (Eds): Lipophilicity in Drug Action and Toxicology. VCH, Weinheim, 1996, p. 173.
33. ACD/logP 1.0, Advanced Chemistry Development Inc., Toronto, Canada.
34. Mayer, J. M., Van de Waterbeemd, H., Testa, B.: Eur. J. Med. Chem. 17, 17 (1982).
35. Novák K., Kollár Gy., Szász Gy.: Magy. Kém. F. 95, 73 (1989).
36. Mannhold, R., Dross, K. P., Rekker, R.: Quant. Struct.-Act. Relat. 9, 21 (1990).
37. Takács-Novák, K., Avdeef, A.: J. Pharmaceut. Biomed. Anal. 14, 1405 (1996).
38. MOLGEN, CHERS, Bratislava, Slowak Republic.
39. SYBYL v. 6.2, Tripos GmbH, München, Germany.
40. Prets, S., Jungreithmair, A., Chiba, P., Ecker, G.: Sci. Pharm. 64, 627 (1996).
41. Domány, Gy., Gizur, T., Gere, A., Takács-Novák, K., Farsang, Gy., Ferenczy, Gy., Demeter, M.: Eur. J. Med. Chem. (közlésre benyújtva)
42. Carrupt, P.-A., Gaillard, P., Billois, F., Weber, P., Testa, B.: The Molecular Lipophilicity Potential (MLP): A New Tool for logP Calculations and Docking and in Comparative Molecular Field Analyses (CoMFA). In: Pliska, V., Testa, B., Van de Waterbeemd, H. (Eds): Lipophilicity in Drug Action and Toxicology, VCH, Weinheim, 1996, p. 195.
43. Testa, B., Kier, L. B.: Med. Res. Rev. 17, 303 (1997).